+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Controlled Release Drug Delivery Market by Type (Chemically-Controlled, Diffusion-Controlled, Dissolution-Controlled), Technology (Liposomes, Microencapsulation, Microspheres), Drug Type, Application, End User - Global Forecast 2025-2030- Product Image
Controlled Release Drug Delivery Market by Type (Chemically-Controlled, Diffusion-Controlled, Dissolution-Controlled), Technology (Liposomes, Microencapsulation, Microspheres), Drug Type, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Controlled Release Drug Delivery Market by Type (Chemically-Controlled, Diffusion-Controlled, Dissolution-Controlled), Technology (Liposomes, Microencapsulation, Microspheres), Drug Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337450
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The controlled release drug delivery market is entering a transformative phase, shaped by scientific innovation, expanding therapeutic applications, and shifting regulatory and trade environments. Senior leaders are navigating increasing demands for precision therapies, supply chain resilience, and competitive differentiation in a sector where optimized formulation and delivery directly influence patient outcomes and portfolio value.

Market Snapshot: Controlled Release Drug Delivery Market Size and Growth

The controlled release drug delivery market grew from USD 46.70 billion in 2024 to USD 51.08 billion in 2025. It is expected to continue growing at a CAGR of 9.31%, reaching USD 79.70 billion by 2030.

Scope & Segmentation

This research comprehensively analyzes the full spectrum of the controlled release drug delivery sector, with a detailed breakdown by technology, drug type, application, end user, and regional market. The following segmentations capture the diversity and complexity of the current landscape:

  • Type: Chemically-Controlled (Iontophoresis, pH-Sensitive, Protonation), Diffusion-Controlled, Dissolution-Controlled, Osmotic, Stimuli-Induced (Magnetic, Temperature, Ultrasound).
  • Technology: Liposomes (Conventional, Ligand-Targeted, PEGylated), Microencapsulation (Coacervation, Solvent Evaporation, Spray Drying), Microspheres (Chitosan, Gelatin, PLGA), Nanoparticles (Dendrimer, Inorganic, Lipid-Based, Polymeric).
  • Drug Type: Biologics (Monoclonal Antibodies, Peptides, Proteins, Vaccines), Small Molecule.
  • Application: Cardiovascular, CNS Disorders, Infectious Diseases, Oncology, Pain Management.
  • End User: Clinics, Home Healthcare, Hospitals, Specialty Centers.
  • Regional Markets: Americas (including leading US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, and others), Asia-Pacific (China, India, Japan, South Korea, among others).
  • Leading Companies: Johnson & Johnson, Pfizer Inc., F. Hoffmann-La Roche Ltd, AbbVie Inc., Merck & Co., Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc.

Key Takeaways for Decision-Makers

  • Controlled release technologies enable therapeutic precision and patient-centric care by overcoming conventional dosing limitations.
  • Scientific advances, such as biodegradable polymers and nanotechnology, are driving the evolution toward combination treatments and sustained delivery systems.
  • Adoption of adaptive manufacturing and partnerships with research centers allows companies to accelerate pipeline development and respond to changing regulatory standards.
  • Regional differences in regulation, manufacturing capability, and technology adoption significantly affect entry strategies and growth prospects across the Americas, Europe, Middle East & Africa, and Asia-Pacific.
  • Competitive positioning is influenced by investments in proprietary materials, targeted acquisitions, and agile responses to external changes such as trade policies.

Impact of US Tariffs on Supply Chain and Cost Structures

The 2025 imposition of US tariffs has introduced new complexities to global supply chains for controlled release drug delivery platforms. Increased costs for specialty polymers and other input materials have prompted market players to adjust supplier networks and enhance domestic manufacturing readiness. Regulatory requirements have tightened, requiring enhanced traceability and closer coordination with local suppliers. Companies are responding by investing in alternative raw materials and scalable manufacturing methods to offset cost challenges without sacrificing product quality or performance.

Methodology & Data Sources

This report employs a thorough multi-layered research approach. Primary data were captured through interviews with industry experts, such as formulation scientists, regulatory specialists, and manufacturing leads. Secondary sources included peer-reviewed publications, patent filings, and market white papers. A structured survey informed technology adoption and pipeline trends, supported by cross-verification through public filings and regulatory databases. Rigorous validation checks and consistency reviews ensured data integrity throughout the analytic process.

Why This Report Matters for Senior Leaders

  • Aligns R&D and investment decisions with practical insights into emerging therapeutic technologies, supply chain shifts, and evolving regulatory demands.
  • Equips executives to benchmark against leading strategies for market entry, competitive positioning, and product differentiation across diverse global segments.
  • Supports the formulation of action-oriented roadmaps for value creation and sustainable portfolio growth, rooted in robust analytics and transparent research processes.

Conclusion

The controlled release drug delivery market is undergoing rapid evolution, with scientific breakthroughs, targeted manufacturing expansion, and regulatory adaptation shaping future value opportunities. Leaders equipped with nuanced intelligence and clear segmentation strategies are positioned to drive sustainable growth and advance patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in biodegradable polymer-based microspheres for sustained drug release over several weeks
5.2. Implementation of implantable microchip platforms enabling programmable personalized dosing regimens
5.3. Development of pH-responsive nanocarriers for precise targeted gastrointestinal drug release profiles
5.4. Integration of artificial intelligence-driven predictive modeling in controlled release formulation optimization
5.5. Expansion of 3D-printed multi-layered oral tablets offering complex temporal and spatial drug release patterns
5.6. Emergence of long-acting injectable monoclonal antibody therapies with biodegradable sustained release matrices
5.7. Utilization of thermoresponsive hydrogel implants for on-demand drug delivery in chronic pain management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Controlled Release Drug Delivery Market, by Type
8.1. Introduction
8.2. Chemically-Controlled
8.2.1. Iontophoresis
8.2.2. pH Sensitive
8.2.3. Protonation
8.3. Diffusion-Controlled
8.4. Dissolution-Controlled
8.5. Osmotic
8.6. Stimuli-Induced
8.6.1. Magnetic
8.6.2. Temperature
8.6.3. Ultrasound
9. Controlled Release Drug Delivery Market, by Technology
9.1. Introduction
9.2. Liposomes
9.2.1. Conventional
9.2.2. Ligand-Targeted
9.2.3. PEGylated
9.3. Microencapsulation
9.3.1. Coacervation
9.3.2. Solvent Evaporation
9.3.3. Spray Drying
9.4. Microspheres
9.4.1. Chitosan
9.4.2. Gelatin
9.4.3. PLGA
9.5. Nanoparticles
9.5.1. Dendrimer
9.5.2. Inorganic
9.5.3. Lipid Based
9.5.4. Polymeric
10. Controlled Release Drug Delivery Market, by Drug Type
10.1. Introduction
10.2. Biologics
10.2.1. Monoclonal Antibodies
10.2.2. Peptides
10.2.3. Proteins
10.2.4. Vaccines
10.3. Small Molecule
11. Controlled Release Drug Delivery Market, by Application
11.1. Introduction
11.2. Cardiovascular
11.3. CNS Disorders
11.4. Infectious Diseases
11.5. Oncology
11.6. Pain Management
12. Controlled Release Drug Delivery Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Healthcare
12.4. Hospitals
12.5. Specialty Centers
13. Americas Controlled Release Drug Delivery Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Controlled Release Drug Delivery Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Controlled Release Drug Delivery Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Pfizer Inc.
16.3.3. F. Hoffmann-La Roche Ltd
16.3.4. AbbVie Inc.
16.3.5. Merck & Co., Inc.
16.3.6. Novartis AG
16.3.7. Sanofi S.A.
16.3.8. Bristol-Myers Squibb Company
16.3.9. GlaxoSmithKline plc
16.3.10. AstraZeneca plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CONTROLLED RELEASE DRUG DELIVERY MARKET: RESEARCHAI
FIGURE 26. CONTROLLED RELEASE DRUG DELIVERY MARKET: RESEARCHSTATISTICS
FIGURE 27. CONTROLLED RELEASE DRUG DELIVERY MARKET: RESEARCHCONTACTS
FIGURE 28. CONTROLLED RELEASE DRUG DELIVERY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH SENSITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH SENSITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PROTONATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PROTONATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DIFFUSION-CONTROLLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DIFFUSION-CONTROLLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DISSOLUTION-CONTROLLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DISSOLUTION-CONTROLLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TEMPERATURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TEMPERATURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIGAND-TARGETED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIGAND-TARGETED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PEGYLATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PEGYLATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SOLVENT EVAPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SOLVENT EVAPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SPRAY DRYING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SPRAY DRYING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHITOSAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY GELATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY GELATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PLGA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PLGA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DENDRIMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DENDRIMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INORGANIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INORGANIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPID BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPID BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CNS DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 174. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 175. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 176. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 177. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 178. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 179. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 180. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 181. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 184. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 185. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 186. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 187. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 190. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 191. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 198. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 199. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 200. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 201. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY LIPOSOMES, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROENCAPSULATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICROSPHERES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY NANOPARTICLES, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY-CONTROLLED, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STIMULI-INDUCED, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM CONTROLLED RELEASE DRUG DEL

Samples

Loading
LOADING...

Companies Mentioned

  • Johnson & Johnson
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • AstraZeneca plc

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 51.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 79.7 Billion
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030 - Product Image

Controlled-Release Drug Delivery Technology Market by Technology, Route Of Administration, Therapeutic Area, Drug Type, Formulation, End User - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Controlled Release Drug Delivery - Global Strategic Business Report - Product Image

Controlled Release Drug Delivery - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Controlled Release Drug Delivery Market Report 2025 - Product Image

Controlled Release Drug Delivery Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Liposome Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Liposome Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Controlled Drug Delivery Market

The Controlled Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the development and delivery of drugs to patients. Controlled Drug Delivery is a type of drug delivery system that allows for the precise and controlled release of drugs over a predetermined period of time. This type of drug delivery system is beneficial for patients who require a steady and consistent dose of medication over a long period of time. It also helps to reduce the risk of side effects and drug interactions. The Controlled Drug Delivery market is composed of a variety of companies that specialize in the development and delivery of controlled drug delivery systems. These companies include Novartis, Pfizer, Merck, Sanofi, and Johnson & Johnson. Additionally, there are a number of smaller companies that specialize in the development of drug delivery systems, such as AptarGroup, 3M, and West Pharmaceutical Services. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.